
US Regulator Approves New Drug for Pancreatic Cancer Treatment
US FDA approves new pancreatic cancer drug, priced at $40,000 per month, according to Turkish media reports.
Aug 27, 2026 ยท 2 min read
183 views
Dansoman ๐ | Developer | Making the world better one day at a time

US FDA approves new pancreatic cancer drug, priced at $40,000 per month, according to Turkish media reports.